Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 11 04:00PM ET
14.37
Dollar change
-0.15
Percentage change
-1.03
%
Index- P/E- EPS (ttm)-2.55 Insider Own1.24% Shs Outstand492.85M Perf Week-1.98%
Market Cap7.10B Forward P/E14.67 EPS next Y0.98 Insider Trans1.97% Shs Float488.20M Perf Month-0.14%
Income-1255.00M PEG- EPS next Q0.12 Inst Own97.75% Short Float2.54% Perf Quarter7.64%
Sales4.49B P/S1.58 EPS this Y3.49% Inst Trans0.34% Short Ratio2.57 Perf Half Y0.14%
Book/sh12.02 P/B1.20 EPS next Y6.31% ROA-8.49% Short Interest12.42M Perf Year45.45%
Cash/sh0.84 P/C17.08 EPS next 5Y10.47% ROE-18.78% 52W Range8.52 - 18.80 Perf YTD-3.56%
Dividend Est.- P/FCF16.71 EPS past 5Y- ROI-11.00% 52W High-23.56% Beta1.40
Dividend TTM- Quick Ratio1.75 Sales past 5Y9.00% Gross Margin43.12% 52W Low68.66% ATR (14)0.54
Dividend Ex-Date- Current Ratio2.93 EPS Y/Y TTM-1186.31% Oper. Margin6.68% RSI (14)48.63 Volatility2.86% 4.19%
Employees9800 Debt/Eq0.96 Sales Y/Y TTM3.74% Profit Margin-27.94% Recom1.86 Target Price18.90
Option/ShortYes / Yes LT Debt/Eq0.92 EPS Q/Q48.60% Payout- Rel Volume0.58 Prev Close14.52
Sales Surprise3.14% EPS Surprise25.16% Sales Q/Q12.02% EarningsNov 07 BMO Avg Volume4.84M Price14.37
SMA20-0.18% SMA500.40% SMA200-5.06% Trades Volume2,800,844 Change-1.03%
Date Action Analyst Rating Change Price Target Change
Sep-19-24Downgrade Morgan Stanley Overweight → Equal-Weight $17 → $15
Jan-05-24Upgrade Stifel Hold → Buy $13 → $20
Dec-19-23Initiated Jefferies Buy $17
Dec-15-23Upgrade Morgan Stanley Equal-Weight → Overweight $16
Dec-07-23Initiated Exane BNP Paribas Outperform $18
Apr-20-23Upgrade Barclays Equal Weight → Overweight $14
Aug-18-22Downgrade Morgan Stanley Overweight → Equal-Weight $37 → $22
Aug-16-22Downgrade JP Morgan Overweight → Neutral $28 → $24
Jul-21-22Downgrade Goldman Buy → Sell $32 → $19
Jul-12-22Initiated Piper Sandler Neutral $22
Oct-11-24 09:14AM
Oct-10-24 08:00AM
Oct-09-24 11:23AM
Oct-08-24 08:43PM
Oct-07-24 04:19PM
10:35AM Loading…
Sep-20-24 10:35AM
Sep-19-24 03:08PM
01:42PM
12:50PM
Sep-13-24 07:30AM
Aug-28-24 06:30AM
Aug-20-24 06:27AM
Aug-15-24 08:27AM
Aug-13-24 01:49PM
Aug-09-24 02:35AM
03:45PM Loading…
Aug-08-24 03:45PM
09:30AM
07:35AM
06:28AM
Aug-06-24 01:00PM
Aug-05-24 09:16AM
Aug-01-24 03:14PM
10:01AM
Jul-30-24 08:27AM
Jul-25-24 01:18PM
Jul-22-24 02:42PM
10:18AM
Jul-18-24 08:00AM
Jul-15-24 03:20PM
Jul-12-24 12:04PM
03:22PM Loading…
Jul-10-24 03:22PM
01:23PM
Jul-09-24 08:30AM
08:28AM
Jul-08-24 02:09PM
Jun-27-24 04:12PM
06:27AM
Jun-07-24 12:00PM
Jun-06-24 08:00AM
May-28-24 07:30PM
06:27AM
May-24-24 02:39AM
May-23-24 04:03PM
May-21-24 08:00AM
May-13-24 09:17AM
May-09-24 08:54PM
11:33AM
10:26AM
09:44AM
07:43AM
03:05AM
May-08-24 04:04PM
02:00PM
12:32PM
09:30AM
09:18AM
07:52AM
07:25AM
06:28AM
May-06-24 09:15AM
Apr-25-24 11:27AM
Apr-23-24 08:30AM
Apr-21-24 10:39AM
Apr-17-24 08:00AM
Apr-01-24 07:00AM
06:39AM
06:30AM
Mar-31-24 11:37PM
Mar-13-24 02:21PM
Mar-12-24 07:00PM
Mar-05-24 10:15AM
Mar-04-24 08:33AM
Feb-29-24 03:30PM
01:08PM
08:00AM
07:03AM
Feb-28-24 10:58AM
Feb-26-24 11:41PM
02:15PM
09:30AM
06:52AM
06:27AM
Feb-22-24 08:00AM
Feb-21-24 09:15AM
Feb-19-24 10:00AM
Feb-15-24 07:00AM
Feb-13-24 01:09PM
Feb-09-24 10:15AM
Feb-08-24 02:46PM
08:00AM
Feb-07-24 01:25PM
Feb-05-24 07:01AM
06:48AM
06:36AM
06:33AM
06:33AM
Jan-18-24 08:22PM
Jan-17-24 08:30AM
Jan-08-24 07:35AM
Jan-02-24 08:33AM
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Harrington Michael JDirectorAug 22 '24Buy14.853,50051,97481,094Aug 26 05:05 PM
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORAug 12 '24Buy13.01100,0001,300,610145,000Aug 13 09:04 AM
DOYLE WILLIAM FDirectorMay 21 '24Buy16.9815,000254,70076,330May 23 04:33 PM
DOYLE WILLIAM FDirectorMar 08 '24Buy16.3015,000244,50061,330Mar 12 04:32 PM
Harrington Michael JDirectorMar 08 '24Buy16.293,10050,49477,594Mar 12 04:30 PM
HOOVER R DAVIDDirectorMar 06 '24Buy16.1420,000322,808185,000Mar 08 05:09 PM